Literature DB >> 8940453

Comparison of the Roche AMPLICOR MYCOBACTERIUM assay and Digene SHARP Signal System with in-house PCR and culture for detection of Mycobacterium tuberculosis in respiratory specimens.

T S Huang1, Y C Liu, H H Lin, W K Huang, D L Cheng.   

Abstract

Two commercial primer kits and detection systems, the Roche AMPLICOR MYCOBACTERIUM test and the Digene primer-probe kit with the SHARP Signal System, were compared to in-house PCR as well as standard culture techniques. For the 27 culture-positive specimens, the Roche AMPLICOR MYCOBACTERIUM test detected 20 specimens, the Digene system detected 19, and in-house PCR detected 21. Of the 86 culture-negative specimens, 13 were positive by the Roche AMPLICOR MYCOBACTERIUM test, 16 were positive by the Digene system, and 21 were positive by in-house PCR. When clinical situations were evaluated, 11 of 13 culture-negative Roche AMPLICOR MYCOBACTERIUM test-positive specimens, 10 of 16 culture-negative Digene system-positive specimens, and 13 of 21 culture-negative-in-house PCR-positive specimens were diagnosed as true-positive specimens. The sensitivities of Roche AMPLICOR MYCOBACTERIUM test, the Digene system, and in-house PCR were 73.81, 69.05, and 80.95%, and the specificities were 97.18, 91.55 and 88.73%, respectively. The positive predictive values were 93.94, 82.86, and 80.95%, and the negative predictive values were 86.25, 83.33, and 88.73%, respectively. For the commercial kits, the Roche AMPLICOR MYCOBACTERIUM test seems to be more sensitive and specific than the Digene system. However, the Roche AMPLICOR MYCOBACTERIUM test cannot be used on nonrespiratory specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940453      PMCID: PMC229464          DOI: 10.1128/jcm.34.12.3092-3096.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Rapid diagnosis of tuberculous meningitis by a simplified nested amplification protocol.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

2.  Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis.

Authors:  N Kennedy; S H Gillespie; A O Saruni; G Kisyombe; R McNerney; F I Ngowi; S Wilson
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

3.  Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.

Authors:  G Levée; P Glaziou; B Gicquel; S Chanteau
Journal:  Res Microbiol       Date:  1994-01       Impact factor: 3.992

4.  Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA.

Authors:  V Jonas; M J Alden; J I Curry; K Kamisango; C A Knott; R Lankford; J M Wolfe; D F Moore
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Detection of Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis method and polymerase chain reaction.

Authors:  L Folgueira; R Delgado; E Palenque; A R Noriega
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Comparison of Amplicor, in-house PCR, and conventional culture for detection of Mycobacterium tuberculosis in clinical samples.

Authors:  J Schirm; L A Oostendorp; J G Mulder
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization.

Authors:  F S Nolte; B Metchock; J E McGowan; A Edwards; O Okwumabua; C Thurmond; P S Mitchell; B Plikaytis; T Shinnick
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Ability of PCR assay to identify Mycobacterium tuberculosis in BACTEC 12B vials.

Authors:  B A Forbes; K E Hicks
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test.

Authors:  R F D'Amato; A A Wallman; L H Hochstein; P M Colaninno; M Scardamaglia; E Ardila; M Ghouri; K Kim; R C Patel; A Miller
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

10.  Cloning and characterization of the gene for immunogenic protein MPB64 of Mycobacterium bovis BCG.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; C Abe; S Nagai; K Terasaka; T Yamada
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

View more
  6 in total

Review 1.  Innovative low cost technologies for biomedical research and diagnosis in developing countries.

Authors:  Josefina Coloma; Eva Harris
Journal:  BMJ       Date:  2004-11-13

Review 2.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  Comparison of a nonradiometric liquid-medium method (MB REDOX) with the BACTEC system for growth and identification of mycobacteria in clinical specimens.

Authors:  Y C Liu; T S Huang; W K Huang
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Four-year experience of use of the Cobas Amplicor system for rapid detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory specimens in Greece.

Authors:  S Levidiotou; G Vrioni; E Galanakis; E Gesouli; C Pappa; D Stefanou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-03       Impact factor: 3.267

Review 5.  Molecular diagnostics in tuberculosis: basis and implications for therapy.

Authors:  Seetha V Balasingham; Tonje Davidsen; Irena Szpinda; Stephan A Frye; Tone Tønjum
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

6.  Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with in-house PCR and culture for detection of M. tuberculosis.

Authors:  B R Eing; A Becker; A Sohns; R Ringelmann
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.